103 related articles for article (PubMed ID: 3983401)
1. Radioimmunodetection of melanoma utilizing In-111 96.5 monoclonal antibody: a preliminary report.
Halpern SE; Dillman RO; Witztum KF; Shega JF; Hagan PL; Burrows WM; Dillman JB; Clutter ML; Sobol RE; Frincke JM
Radiology; 1985 May; 155(2):493-9. PubMed ID: 3983401
[TBL] [Abstract][Full Text] [Related]
2. Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018.
Murray JL; Rosenblum MG; Lamki L; Glenn HJ; Krizan Z; Hersh EM; Plager CE; Bartholomew RM; Unger MW; Carlo DJ
J Nucl Med; 1987 Jan; 28(1):25-33. PubMed ID: 3794809
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody imaging of human melanoma. Radioimmunodetection by subcutaneous or systemic injection.
Lotze MT; Carrasquillo JA; Weinstein JN; Bryant GJ; Perentesis P; Reynolds JC; Matis LA; Eger RR; Keenan AM; Hellström I
Ann Surg; 1986 Sep; 204(3):223-35. PubMed ID: 3753057
[TBL] [Abstract][Full Text] [Related]
4. Immunospecific saturable clearance mechanisms for indium-111-labeled anti-melanoma monoclonal antibody 96.5 in humans.
Murray JL; Lamki LM; Shanken LJ; Blake ME; Plager CE; Benjamin RS; Schweighardt S; Unger MW; Rosenblum MG
Cancer Res; 1988 Aug; 48(15):4417-22. PubMed ID: 3390837
[TBL] [Abstract][Full Text] [Related]
5. [Radioimmunoimaging of malignant melanoma with In-111 labeled monoclonal antibody 96.5 and ZME-0.18].
Ishii K; Nishiyama S; Oyamada H; Endo K
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1194-203. PubMed ID: 2730019
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunodetection of human melanoma with indium-111-labeled monoclonal antibodies.
Taylor A; Milton W; Eyre H; Wu FP; Christian P; Alazraki N; Datz F; Unger MW
NCI Monogr; 1987; (3):25-31. PubMed ID: 3821915
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunodetection of human melanoma with indium-111-labeled monoclonal antibody.
Taylor A; Milton W; Eyre HP; Christian P; Wu F; Hagan P; Alazraki N; Datz FL; Unger M
J Nucl Med; 1988 Mar; 29(3):329-37. PubMed ID: 3346743
[TBL] [Abstract][Full Text] [Related]
8. Improved tumor localization with increasing dose of indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody ZCE-025 in metastatic colorectal cancer.
Patt YZ; Lamki LM; Haynie TP; Unger MW; Rosenblum MG; Shirkhoda A; Murray JL
J Clin Oncol; 1988 Aug; 6(8):1220-30. PubMed ID: 3045263
[TBL] [Abstract][Full Text] [Related]
9. Radioimaging of melanoma using 99mTc-labeled Fab fragment reactive with a high molecular weight melanoma antigen.
Lamki LM; Zukiwski AA; Shanken LJ; Legha SS; Benjamin RS; Plager CE; Salk DF; Schroff RW; Murray JL
Cancer Res; 1990 Feb; 50(3 Suppl):904s-908s. PubMed ID: 2297740
[TBL] [Abstract][Full Text] [Related]
10. Scintigraphic detection of metastatic melanoma using indium 111/DTPA conjugated anti-gp240 antibody (ZME-018).
Kirkwood JM; Neumann RD; Zoghbi SS; Ernstoff MS; Cornelius EA; Shaw C; Ziyadeh T; Fine JA; Unger MW
J Clin Oncol; 1987 Aug; 5(8):1247-55. PubMed ID: 3625247
[TBL] [Abstract][Full Text] [Related]
11. Role of technetium 99m-labeled monoclonal antibody in the management of melanoma patients.
Blend MJ; Ronan SG; Salk DJ; Gupta TK
J Clin Oncol; 1992 Aug; 10(8):1330-7. PubMed ID: 1634923
[TBL] [Abstract][Full Text] [Related]
12. Phase 1 immunolymphoscintigraphy with an In-111-labeled antimelanoma monoclonal antibody.
Engelstad BL; Spitler LE; Del Rio MJ; Ramos EC; Rosendorf LL; Reinhold CE; Khentigan A; Huberty JP; Corpuz SW; Lee HM
Radiology; 1986 Nov; 161(2):419-22. PubMed ID: 3763912
[TBL] [Abstract][Full Text] [Related]
13. Scintigraphy with In-111-labeled monoclonal antitumor antibodies: kinetics, biodistribution, and tumor detection.
Halpern SE; Haindl W; Beauregard J; Hagan P; Clutter M; Amox D; Merchant B; Unger M; Mongovi C; Bartholomew R
Radiology; 1988 Aug; 168(2):529-36. PubMed ID: 3393677
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunoimaging in malignant melanoma patients with the use of indium-111-labeled antimelanoma monoclonal antibody (ZME-018) to high-molecular-weight antigen.
Murray JL; Rosenblum MG; Lamki L; Haynie TP; Glenn HJ; Plager CE; Unger MW; Carlo DJ; Hersh EM
NCI Monogr; 1987; (3):3-9. PubMed ID: 3821916
[TBL] [Abstract][Full Text] [Related]
15. Sequential use of indium-111 labeled monoclonal antibodies 96.5 and ZME-018 does not increase detection sensitivity for metastatic melanoma.
Frontiera M; Murray JL; Lamki L; Thomas J; Satterlee W; Schmelter R; Rosenblum MG; Khazaeli MB; Unger MW; Robinson WA
Clin Nucl Med; 1989 May; 14(5):357-66. PubMed ID: 2656042
[TBL] [Abstract][Full Text] [Related]
16. Colorectal carcinoma metastases: detection with In-111-labeled monoclonal antibody CCR 086.
Abdel-Nabi HH; Levine G; Lamki LM; Murray JL; Tauxe WN; Shah AN; Patt YZ; Doerr RJ; Klein HA; Gona J
Radiology; 1990 Jul; 176(1):117-22. PubMed ID: 2353080
[TBL] [Abstract][Full Text] [Related]
17. Effect of antibody dose on the imaging and biodistribution of indium-111 9.2.27 anti-melanoma monoclonal antibody.
Carrasquillo JA; Abrams PG; Schroff RW; Reynolds JC; Woodhouse CS; Morgan AC; Keenan AM; Foon KA; Perentesis P; Marshall S
J Nucl Med; 1988 Jan; 29(1):39-47. PubMed ID: 3335926
[TBL] [Abstract][Full Text] [Related]
18. Uptake of indium-111-labeled monoclonal antibody ZME-018 as a function of tumor size in a patient with melanoma.
Macey DJ; Denardo SJ; Denardo GL; Goodnight JK; Unger MW
Am J Physiol Imaging; 1988; 3(1):1-6. PubMed ID: 3390350
[TBL] [Abstract][Full Text] [Related]
19. Effect of unlabelled monoclonal antibody (MoAb) on biodistribution of 111indium labelled (MoAb).
Lamki LM; Murray JL; Rosenblum MG; Patt YZ; Babaian R; Unger MW
Nucl Med Commun; 1988 Aug; 9(8):553-64. PubMed ID: 3173914
[TBL] [Abstract][Full Text] [Related]
20. Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma.
Siccardi AG; Buraggi GL; Callegaro L; Mariani G; Natali PG; Abbati A; Bestagno M; Caputo V; Mansi L; Masi R
Cancer Res; 1986 Sep; 46(9):4817-22. PubMed ID: 3731128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
